sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
20-Oct-2014 07:29
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 776-800 out of 902.

<< < 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>

Public Release: 5-Feb-2013
Human bacteria sequencing project involving CU raises $340,000 online
In hopes of better understanding nutrition and health, the University of Colorado Boulder is playing the leading science role in a "crowdfunding" effort that has raised more than $340,000 for a project designed to sequence the gut bacteria of thousands of people around the world.
American Gut Project

Contact: Rob Knight
Rob.Knight@colorado.edu
303-492-1984
University of Colorado at Boulder

Public Release: 5-Feb-2013
Cell Metabolism
Scientists discover protein that allows safe recycling of iron from old red blood cells
Scientists have long hypothesized that our bodies must have a special protein 'container' for transporting heme -- the form of iron found in living things -- during the breakdown and recycling of old red cells and other types of heme metabolism. Now a research team led by scientists from the University of Maryland have identified this long-sought heme-iron transporter and shown that it is the same HRG1 protein found in a common microscopic worm.
National Institutes of Health

Contact: Lee Tune
ltune@umd.edu
301-405-4679
University of Maryland

Public Release: 4-Feb-2013
Proceedings of the National Academy of Sciences
Injection-free vaccination technique could address global vaccine challenge for HIV, malaria
Scientists at King's College London have demonstrated the ability to deliver a dried live vaccine to the skin without a traditional needle, and shown for the first time that this technique is powerful enough to enable specialized immune cells in the skin to kick-start the immunizing properties of the vaccine.
Bill & Melinda Gates Foundation

Contact: Katherine Barnes
katherine.barnes@kcl.ac.uk
44-207-848-3076
King's College London

Public Release: 1-Feb-2013
The FASEB Journal
Genetically modified tobacco plants produce antibodies to treat rabies
Smoking tobacco is bad for your health, but a genetically altered version of the plant might provide an inexpensive cure for the deadly rabies virus. In a new report in The FASEB Journal, scientists produced a monoclonal antibody in transgenic tobacco plants shown to neutralize the rabies virus. This antibody works by preventing the virus from attaching to nerve endings around the bite site and keeping the virus from traveling to the brain.

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology

Public Release: 31-Jan-2013
PLOS ONE
UCSB anthropologists study effects of modernization on physical activity and heart disease
Heart disease continues to be the leading cause of death in the United States, and a sedentary lifestyle is often cited as a major contributing factor. Among the Tsimane, an indigenous population in the lowlands of Bolivia's Amazon basin, however, indicators of heart disease are practically non-existent –– cholesterol is low, obesity is rare, and smoking is uncommon.

Contact: Andrea Estrada
andrea.estrada@ia.ucsb.edu
805-893-4620
University of California - Santa Barbara

Public Release: 31-Jan-2013
PLOS Pathogens
Placental blood flow can influence malaria during pregnancy
Malaria in pregnancy causes a range of adverse effects, including abortions and stillbirths. In the latest issue of the journal PLOS Pathogen, researchers from the Instituto Gulbenkian de Ciência, Portugal, observed, for the first time, the mouse placental circulation and showed how it can influence the malaria parasite behavior and infection. Their results indicate a higher accumulation of parasites in placental regions with low blood flow, being these areas more prone to an inflammatory response.
Fundação para a Ciência e a Tecnologia

Contact: Ana Mena
anamena@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia

Public Release: 31-Jan-2013
PLOS Neglected Tropical Diseases
African Programme for Onchocerciasis Control 1995-2015: Model-estimated health impact and cost
A relatively inexpensive program set up to combat river blindness has resulted in major health improvements in Africa, shows a study conducted by Erasmus University Medical Center researchers. The study, due to be published Jan. 31 in PLOS Neglected Tropical Diseases, shows that US $250 million helped cure or prevent the major symptoms of onchocerciasis in millions of people. In collaboration with the Management of the African Programme for Onchocerciasis Control (APOC), the researchers calculated the health impact of APOC.

Contact: Matthew Lopez
mlopez@plos.org
415-568-3174
PLOS

Public Release: 30-Jan-2013
Stem Cells Translational Medicine
'Petri dish lens' gives hope for new eye treatments
A cure for congenital sight impairment caused by lens damage is closer following research by scientists at Monash University.
Australian Research Council

Contact: Emily Walker
emily.walker@monash.edu
61-399-034-844
Monash University

Public Release: 30-Jan-2013
Proceedings of the National Academy of Sciences
UNC scientists unveil a superbug's secret to antibiotic resistance
Many strains of the bacterium Staphyloccocus aureus are already resistant to all antibiotics except vancomycin. But as bacteria are becoming resistant to this once powerful antidote, S. aureus has moved one step closer to becoming an unstoppable killer. Now, researchers at the University of North Carolina at Chapel Hill have not only identified the mechanism by which vancomycin resistance spreads from one bacterium to the next, but have suggested ways to potentially stop the transfer.
National Institutes of Health

Contact: Thania Benios
thania_benios@unc.edu
919-962-8596
University of North Carolina at Chapel Hill

Public Release: 30-Jan-2013
Journal of Neuroscience
New drug target identified for multiple sclerosis and Alzheimer's disease
Researchers at Boston University School of Medicine report that the protein Klotho plays an important role in the health of myelin, the insulating material allowing for the rapid communication between nerve cells. These findings may lead to new therapies for multiple sclerosis and Alzheimer's disease, in which white matter abnormalities are also common but have been largely ignored.

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center

Public Release: 30-Jan-2013
Lancet Neurology
Study finds parasites and poor antenatal care are main causes of epilepsy in Africa
The largest study of epilepsy in sub-Saharan Africa to date reveals that programs to control parasitic diseases and access to better antenatal care could substantially reduce the prevalence of the disease in this region.
Wellcome Trust

Contact: Jen Middleton
j.middleton@wellcome.ac.uk
44-207-611-7262
Wellcome Trust

Public Release: 30-Jan-2013
New England Journal of Medicine
Antibiotics cut death rate for malnourished children
Severely malnourished children are far more likely to recover and survive when given antibiotics along with a therapeutic peanut-based food than children who are simply treated with the therapeutic food alone, researchers at Washington University School of Medicine in St. Louis have found.
Hickey Family Foundation, National Institutes for Health

Contact: Elizabethe Holland Durando
elizabethe.durando@wustl.edu
314-286-0119
Washington University School of Medicine

Public Release: 30-Jan-2013
PLOS ONE
Tenofovir gel wins out in drug absorption study, but HIV prevention trials say differently
A study looking at how the body absorbs the antiretroviral drug tenofovir as either an oral tablet or a vaginal gel found the gel achieves much higher concentrations of active drug in vaginal tissue than the tablet, suggesting it to be highly effective in protecting against HIV through vaginal sex. But results of HIV prevention trials have shown differently, leading researchers to conclude that effectiveness of tenofovir products depends not just on tissue concentrations.
National Institutes of Health

Contact: Clare Collins
collcx@upmc.edu
412-641-7299
Microbicide Trials Network

Public Release: 30-Jan-2013
Science Translational Medicine
Forsyth scientists gain new understanding of latent tuberculosis
Scientists at the Forsyth have gained new insight on how Tuberculosis (TB) remains a global epidemic. The Forsyth team, and its collaborators from Stanford University, has recently discovered that Mycobacterium tuberculosis, the bacteria that causes TB, can lay dormant and thrive within bone marrow stem cells.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Kelly
jkelly@forsyth.org
617-461-6994
Forsyth Institute

Public Release: 29-Jan-2013
PLOS Medicine
More research into chronic diseases urgently needed in all countries
When considering chronic (non-communicable) diseases, such as cardiovascular disease and diabetes, in low-and-middle countries, a major shift in approach from declaring what needs to be done to using research to prioritize, evaluate, monitor and improve health outcomes is urgently needed, according to international experts from London School of Hygiene & Tropical Medicine writing in this week's PLOS Medicine.

Contact: Sumrina Yousufzia
syousufzai@plos.org
415-568-3164
PLOS

Public Release: 28-Jan-2013
DRI to led efforts in clean water, sanitation and hygiene solutions in developing nations
Dr. Braimah Apambire recently has been selected as the Senior Assistant to the President for Global Sustainability and Director for Water, Sanitation and Hygiene programs at the Desert Research Institute. This opportunity was made possible through a generous three year grant of $500,000 from the Conrad N. Hilton Foundation. It will support Apambire's work with DRI to create a center on Water, Development and Sustainability issues.
Conrad N. Hilton Foundation

Contact: Ashley Conroy
conroy.ashley@dri.edu
702-862-5411
Desert Research Institute

Public Release: 28-Jan-2013
Pandemic Flu Controversies: A Workshop to discuss lessons, policy implications and future challenges
Pandemic controversies: The global response to pandemic influenza must change
"Evil" scientists, deadly viruses and terrorist plots are usually the preserve of Hollywood blockbusters. But when it comes to pandemic influenza, it is the stuff of real life. As controversy about H5N1 bird flu virus research continues, a new paper argues for a new approach to pandemic preparedness.
Economic and Social Research Council STEPS Centre

Contact: Julia Day
j.day@ids.ac.uk
44-012-739-15671
Institute of Development Studies

Public Release: 24-Jan-2013
BMC Cancer
Stigma stymies prostate cancer screening, treatment in Ghana
A new study published in January in the journal BMC Cancer, led by Kosj Yamoah, M.D., Ph.D., a resident in the Department of Radiation Oncology at Thomas Jefferson University and Hospital, takes aim at cancer disparities and stigma by investigating prostate cancer diagnoses and treatment delivery in black men living in the West African region, in order to devise research strategies to help improve health outcomes.

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University

Public Release: 24-Jan-2013
Clinical Chemistry
Fast, low-cost device uses the cloud to speed up diagnostic testing for HIV and more
Columbia biomedical engineering professor Samuel Sia has taken his innovative lab-on-a-chip and developed a way to not only check a patient's HIV status anywhere in the world with just a finger prick, but also synchronize the results automatically and instantaneously with central health-care records -- 10 times faster than the benchtop ELISA. The study, which details field testing in Rwanda, is published online Jan. 18, 2013, in Clinical Chemistry.
US Agency for International Development, Bill and Melinda Gates Foundation

Contact: Holly Evarts
holly.evarts@gmail.com
347-453-7408
Columbia University

Public Release: 22-Jan-2013
Researchers attack HIV's final defenses before drug-resistant mutations emerge
With a new $3.4 million grant from the National Institutes of Health, the University of Missouri is leading a team of researchers who want to stay a step ahead of HIV by finding new pathways for shutting down the virus. The scientists are developing new compounds designed to target an enzyme in HIV called RNase H, which has escaped the reach of existing drugs.
National Institutes of Health

Contact: Laura Gerding
gerdingla@health.missouri.edu
573-882-9193
University of Missouri School of Medicine

Public Release: 17-Jan-2013
Proceedings of the National Academy of Sciences
Fighting sleep: UGA discovery may lead to new treatments for deadly sleeping sickness
While its common name may make it sound almost whimsical, sleeping sickness, or African trypanosomiasis, is in reality a potentially fatal parasitic infection that has ravaged populations in sub-Saharan Africa for decades, and it continues to infect thousands of people every year.

Contact: Roberto Docampo
rdocampo@uga.edu
706-542-8104
University of Georgia

Public Release: 17-Jan-2013
Cell
New insights into how leprosy infection spreads could pave the way for early intervention
A new study, published by Cell Press Jan. 17 in the journal Cell, reveals that the bacteria responsible for leprosy spread infection by hijacking specialized cells in the adult nervous system, reprogramming them into a stem cell-like state, and converting them to muscle-like cells. These findings could lead to the development of new therapeutic strategies for combating bacterial infections and degenerative diseases as well as new tools for regenerative medicine.

Contact: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press

Public Release: 17-Jan-2013
PLOS Computational Biology
Wild animals may contribute to the resurgence of African sleeping sickness
Wild animals may be a key contributor to the continuing spread of African sleeping sickness, new research published in PLOS Computational Biology shows. The West African form of the disease, also known as Gambiense Human African trypanosomiasis, affects around 10,000 people in Africa every year and is deadly if left untreated.
EPIWORK, JST PRESTO program, AXA Research Fund

Contact: Sebastian Funk
sf7@princeton.edu
44-772-602-6766
PLOS

Public Release: 16-Jan-2013
Emerging Infectious Diseases
Recent study suggests bats are reservoir for ebola virus in Bangladesh
EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, released new research on Ebola virus in fruit bats in the peer reviewed journal, Emerging Infectious Diseases.

Contact: Anthony Ramos
ramos@ecohealthalliance.org
212-380-4469
EcoHealth Alliance

Public Release: 16-Jan-2013
PLOS Medicine
U of T and Harvard study finds growing 'weight extremes' in the developing world
Obese and overweight people are gaining weight rapidly in low- and middle-income countries while those who are severely undernourished are not experiencing similar weight gains, according to a University of Toronto and Harvard School of Public Health study.

Contact: Nicole Bodnar
nicole.bodnar@utoronto.ca
416-978-5811
University of Toronto

Showing releases 776-800 out of 902.

<< < 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>